TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 45 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,037,312 | -1.7% | 1,296,416 | 0.0% | 0.77% | +13.3% |
| Q2 2023 | $23,426,237 | +43.8% | 1,296,416 | 0.0% | 0.68% | +41.0% |
| Q1 2023 | $16,295,949 | -14.3% | 1,296,416 | 0.0% | 0.48% | -9.9% |
| Q4 2022 | $19,005,459 | -14.4% | 1,296,416 | 0.0% | 0.53% | -17.1% |
| Q3 2022 | $22,194,000 | +17.3% | 1,296,416 | 0.0% | 0.64% | +8.6% |
| Q2 2022 | $18,927,000 | -13.2% | 1,296,416 | 0.0% | 0.59% | +35.7% |
| Q1 2022 | $21,805,000 | -62.6% | 1,296,416 | -50.0% | 0.44% | -2.9% |
| Q4 2021 | $58,338,000 | +108.8% | 2,592,832 | +100.0% | 0.45% | +10.8% |
| Q3 2021 | $27,937,000 | -62.8% | 1,296,416 | -50.0% | 0.41% | -16.8% |
| Q2 2021 | $75,140,000 | +82.7% | 2,592,832 | +100.0% | 0.49% | -6.2% |
| Q1 2021 | $41,127,000 | -23.2% | 1,296,416 | 0.0% | 0.52% | -9.6% |
| Q4 2020 | $53,580,000 | – | 1,296,416 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |